drugset / Trial / NCT02035800
Bone Resorption, Osteoclastogenesis and Adalimumab
NaSingle-groupOpen-labelBasic science
Summary
Broca II is the prolongation of the original study name BROCA. In BROCA study, only 25 patients participated and it was not enough to concluded clearly our hypothesis.
Timeline
- Start
- 2013-05
- Primary completion
- 2018-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adalimumab | Monoclonal antibody | — | — |